Patapsco Bancorp Inc (PATD) 4.8000 $PATD Howard Bancorp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Patapsco Bancorp Inc (PATD) 4.8000 $PATD

Howard Bancorp announces receipt of necessary stockholder approvals for merger with Patapsco Bancorp
M2 - Fri Jul 24, 7:17AM CDT
Howard Bancorp Inc (Nasdaq:HBMD) revealed on Friday that its stockholders approved the issue of its shares of common stock to the stockholders of Patapsco Bancorp Inc on 22 July 2015, related to the merger of Patapsco into Howard, with Howard remaining as the surviving entity.
HBMD: 13.80 (-0.11)

Howard Bancorp and Patapsco Bancorp Merger Receive all Necessary Stockholder Approvals
Business Wire - Thu Jul 23, 3:59PM CDT
Howard Bancorp, Inc. ("Howard" (Nasdaq: HBMD), announced that on July 22, 2015, its stockholders approved the issuance by Howard of its shares of common stock to the stockholders of Patapsco Bancorp, Inc. ("Patapsco" in connection with the merger of Patapsco into Howard, with Howard as the surviving entity, pursuant to that Agreement and Plan of Merger by and between Howard and Patapsco dated as of March 2, 2015 ("the merger". Howard's stockholders showed overwhelming support for the merger-related share issuance with over 99% of the votes cast voting in favor of the proposal.
HBMD: 13.80 (-0.11)

Howard Bancorp Receives Regulatory Approval for the Acquisition of Patapsco Bancorp, Inc.
Business Wire - Tue Jun 09, 3:15PM CDT
Howard Bancorp, Inc. (NASDAQ: HBMD) announced today that it, along with its banking subsidiary, Howard Bank, have received all required regulatory approvals necessary to proceed with the acquisition of Patapsco Bancorp, Inc., and its banking subsidiary, The Patapsco Bank. The transaction will be voted upon by stockholders of both Howard Bancorp and Patapsco Bancorp at meetings scheduled for July 22, 2015. The deal is anticipated to close on or about August 28, 2015, pending stockholder approval.
HBMD: 13.80 (-0.11)

Howard Bancorp, Inc. Completes $25 Million Common Stock Offering
Business Wire - Tue Jun 02, 1:46PM CDT
Howard Bancorp, Inc. (NASDAQ: HBMD, "Howard", the parent company of Howard Bank, announced today that it has closed on its previously-announced private placement following receipt of stockholder approval. Howard issued an aggregate of 2,173,913 shares of its common stock at a price of $11.50 per share for approximately $25 million in gross proceeds to a limited number of well-regarded previously disclosed institutional bank investors. Howard solicited these capital commitments over a 30-day period beginning in early February and executed agreements with each investor on March 2, 2015. The purchase price represents the closing price of Howard's common stock on the day the offering was commenced and less than a 10% discount to the rolling 20-day average on the date of announcement of the private placement. Howard intends to use the proceeds of the private placement in part to support its acquisition of Patapsco Bancorp, Inc. ("Patapsco" as well as to support continued organic and acquired growth for the combined institution. Howard has no present intent to use the proceeds of the private placement to redeem its preferred stock issued to the U.S. Department of the Treasury under its Small Business Lending Fund (SBLF) program. The Patapsco transaction is subject to various stockholder and regulatory approvals and is expected to close in the third quarter of 2015.
HBMD: 13.80 (-0.11)

Howard Bancorp: Acquisitive Community Bank Positioned To Outperform
Transcend Event Driven Research - at Seeking Alpha - Thu May 28, 8:30PM CDT

HBMD: 13.80 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 10

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 111

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 49

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 0

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 75

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 162

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles